tobramycin
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
University of Milan
Overview
tobramycin is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
tobramycin clinical trials
Explore related
Medical disclaimer. This page summarizes research about tobramycin for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.